ResistanceBio

Private

Menlo Park, CaliforniaHealthcare & Life Scienceshttps://www.resistance.bio

Last Round

Series A

Jan 31, 2024

Est. Valuation

$2.14M

Total Funding Raised

$18.55M

Company Overview

ResistanceBio is a biotechnology company that develops therapeutics and predictive models to combat treatment-resistant cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryoncology therapeuticscancer drug resistanceResCu systemprecision medicineAI drug discoveryin silico drug discoverybiomarker discoverypre-clinical researchtherapeutic target identificationcell culture platformdrug resistance profilingbiotech platformdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ResistanceBio Comps

Public and private peers based on sector, stage, and business model.

ResistanceBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ResistanceBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 31, 2024
Seed	Mar 29, 2021
Accelerator	Mar 1, 2019
Grant	Sep 11, 2017

View all Funding Rounds

ResistanceBio Investors

Notable investors and investment history

ResistanceBio investors
Investor	Rounds
Centennial Investors	Series A
NFX	Series A, Seed
Cantos Ventures	Series A
Awah Ventures	Series A
Brightstone Venture Capital	Series A
Y Combinator	Series A, Seed, Accelerator
Liquid 2 Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 31, 2024
$13M round with participation from NFX and Alumni Ventures.

View all signals

ResistanceBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ResistanceBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ResistanceBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California

Employee Range2

Year Founded2021

Last FundingJan 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.